New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Kowsar

Hyper-Prolactinemia in Men With Idiopathic Dilated Cardiomyopathy: Does It Have any Prognostic Implications?

Nasim Naderi 1 , Hooman Bakhshandeh 1 , * , Maryam Ardeshiri 1 , Fatemeh Barzegari 1 , Ahmad Amin 1 , Sepideh Taghavi 1 and Majid Maleki 1
Authors Information
1 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: August 2014, 3 (3); e19321
  • Published Online: July 28, 2014
  • Article Type: Research Article
  • Received: April 7, 2014
  • Revised: May 14, 2014
  • Accepted: May 24, 2014
  • DOI: 10.5812/cardiovascmed.19321

To Cite: Naderi N, Bakhshandeh H, Ardeshiri M, Barzegari F, Amin A, et al. Hyper-Prolactinemia in Men With Idiopathic Dilated Cardiomyopathy: Does It Have any Prognostic Implications?, Res Cardiovasc Med. 2014 ;3(3):e19321. doi: 10.5812/cardiovascmed.19321.

Abstract
Copyright: Copyright © 2014, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
3.3 Statistical Analysis
4. Results
4.3 Findings in the Patients’ Follow Up
5. Discussion
Acknowledgements
Footnotes
References
  • 1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33(14): 1787-847[DOI][PubMed]
  • 2. Sacca L. Heart failure as a multiple hormonal deficiency syndrome. Circ Heart Fail. 2009; 2(2): 151-6[DOI][PubMed]
  • 3. Opalińska-Ciszek, E. , Niemczyk, S. , Matuszkiewicz-Rowińska, J. . [Prolactin (PRL), thyrotropin (TSH), free thyroid hormones (fT4),(fT3) and testosterone (TTE) level in men with chronic heart failure]. Polish Arch Intern Med. 2005; 113.4: 320
  • 4. Limas CJ, Kroupis C, Haidaroglou A, Cokkinos DV. Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations. Eur J Clin Invest. 2002; 32(2): 74-8[PubMed]
  • 5. Landberg E, Dahlstrom U, Alehagen U. Serum prolactin and macroprolactin in heart failure: no relation to established laboratory or clinical parameters. Ann Clin Biochem. 2011; 48: 51-6[DOI][PubMed]
  • 6. Parissis JT, Farmakis D, Fountoulaki K, Rigas A, Nikolaou M, Paraskevaidis IA, et al. Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failure. Eur J Heart Fail. 2013; 15(10): 1122-30[DOI][PubMed]
  • 7. Wallaschofski H, Lohmann T, Stumpf C, Daniel WG, Garlichs CD. Lack of relevant association between prolactin and immune responses in patients with chronic heart failure. Eur J Clin Invest. 2003; 33(11): 1018[PubMed]
  • 8. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985; 132(8): 919-23[PubMed]
  • 9. Fruhwald FM, Fahrleitner A, Watzinger N, Dobnig H, Schumacher M, Maier R, et al. N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy. Heart. 1999; 82(5): 630-3[PubMed]
  • 10. Fruhwald FM, Fahrleitner A, Watzinger N, Fruhwald S, Dobnig H, Schumacher M, et al. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J. 1999; 20(19): 1415-23[DOI][PubMed]
  • 11. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997; 96(2): 509-16[PubMed]
  • 12. Lamblin N, Mouquet F, Hennache B, Dagorn J, Susen S, Bauters C, et al. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J. 2005; 26(21): 2245-50[DOI][PubMed]
  • 13. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001; 103(13): 1813-8[PubMed]
  • 14. Chopra S, Verghese PP, Jacob JJ. Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy. Indian J Endocrinol Metab. 2012; 16 Suppl 1-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader